marijuana stocks

Form 8-K for LEXARIA CORP.


24-Aug-2015

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the Company’s technology achieves Cannabidiol absorption rate 499% greater than baseline in laboratory testing filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Premier Health Group Inc. (PHGI) (PHGRF) Enters into Definitive Agreement to Acquire Two Operating Pharmacies in Metro Vancouver

Premier Health Enters into Definitive Agreement to Acquire Two Operating Pharmacies in…

Lexaria Bioscience Corp. (LXRP) Proprietary DehydraTECH-Enabled CBD Powders Business Growing Faster than Expected

Lexaria Proprietary DehydraTECH-Enabled CBD Powders Business Growing Faster than Expected Lexaria Bioscience…

Neptune Wellness Solutions Inc. (NEPT) Announces Voluntary Delisting from Toronto Stock Exchange

Neptune Wellness Solutions Inc. Announces Voluntary Delisting from Toronto Stock Exchange Neptune…

$PLPG Secures Investment From Hypur Ventures

Blue Line Protection Group Secures Investment From Hypur Ventures Blue Line Protection…